Sangamo Therapeutics Inc (SGMO) Q4 2020 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Sangamo Fourth Quarter and Full Year 2020 Conference Call. With me this afternoon on this call are several members of the Sangamo Executive Leadership Team, including Sandy Macrae, Chief Executive Officer; Mark McClung, Chief Business Officer; Jason Fontenot, Chief Scientific Officer, Rob Schott, Head of Development and Bettina Cockroft, Chief Medical Officer. This call includes forward-looking statements regarding Sangamo's current expectations.
